Neurogene Inc.

Q2 2026 13F Holders

Symbol
NGNE
CUSIP
64135M105
Type
Equity
Class
COM
Num filings
115
Total reported value, excl. options
$545 M
Manager Report Date Value ($000) Shares Option Type